Optogenetics, visual prosthesis and electrostimulation for retinal dystrophies

Current Opinion in Ophthalmology

Volumn 24, Issue 5, 2013, Pages 407-414

  Garg, Sunir J ^a   Federman, Jay ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Chip implants; Optogenetics; Retina; Retinitis pigmentosa

Indexed keywords

ALGORITHM; ELECTRODE; ELECTROSTIMULATION; HUMAN; INCISION; NERVE CELL; OPTOGENETICS; PARS PLANA VITRECTOMY; PRIORITY JOURNAL; RETINA CELL; RETINA DEGENERATION; RETINA DETACHMENT; RETINA DYSTROPHY; RETINA GANGLION CELL; RETINAL IMPLANT; RETINITIS PIGMENTOSA; REVIEW; VISUAL ACUITY; VISUAL PROSTHESIS; VITRECTOMY; VITREOUS HEMORRHAGE;

ELECTRIC STIMULATION THERAPY; HUMANS; OPTOGENETICS; RETINAL DYSTROPHIES; VISUAL PROSTHESIS;

EID: 84883448269     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e328363829b     Document Type: Review

References (53)

1. Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993; 111:761-772.
2. Berson EL, Rosner B, Sandberg MA, et al. omega-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol 2012; 130:707-711.
3. Berson EL, Rosner B, Sandberg MA, et al. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol 2010; 128:403-411.
4. Maeda T, Dong Z, Jin H, et al. QLT091001, a 9-cis-retinal analog, is well tolerated by retinas of mice with impaired visual cycles. Invest Ophthalmol Vis Sci 2013; 54:455-466.
5. Wright AF, Chakarova CF, Abd El-Aziz MM, Bhattacharya SS. Photoreceptor degeneration: Genetic and mechanistic dissection of a complex trait. Nat Rev Genet 2010; 11:273-284.
6. Sancho-Pelluz J, Arango-Gonzalez B, Kustermann S, et al. Photoreceptor cell death mechanisms in inherited retinal degeneration. Mol Neurobiol 2008; 38:253-269.
7. Busskamp V, Picaud S, Sahel JA, Roska B. Optogenetic therapy for retinitis pigmentosa. Gene therapy 2012; 19:169-175.
8. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009; 8:67-81.
9. Gorostiza P, Isacoff EY. Optical switches for remote and noninvasive control of cell signaling. Science 2008; 322:395-399.
10. Menz MD, Oralkan O, Khuri-Yakub PT, Baccus SA. Precise neural stimulation in the retina using focused ultrasound. J Neurosci 2013; 33:4550-4560.
11. Tufail Y, Matyushov A, Baldwin N, et al. Transcranial pulsed ultrasound stimulates intact brain circuits. Neuron 2010; 66:681-694.
12. Yao JP, Hou WS, Yin ZQ. Optogenetics: A novel optical manipulation tool for medical investigation. Int J Ophthalmol 2012; 5:517-522. Optogenetics offers the possibility of precise targeting of cells of interest
13. Tomita H, Sugano E, Yawo H, et al. Restoration of visual response in aged dystrophic RCS rats using AAV-mediated channelopsin-2 gene transfer. Invest Ophthalmol Vis Sci 2007; 48:3821-3826.
14. Tomita H, Sugano E, Isago H, Tamai M. Channelrhodopsins provide a breakthrough insight into strategies for curing blindness. J Genet 2009; 88:409-415.
15. Tomita H, Sugano E, Isago H, et al. Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats. Exp Eye Res 2010; 90:429-436.
16. Isago H, Sugano E, Wang Z, et al. Age-dependent differences in recovered visual responses in Royal College of Surgeons rats transduced with the Channelrhodopsin-2 gene. J Mol Neurosci 2012; 46:393-400.
17. Bi A, Cui J, Ma YP, et al. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron 2006; 50:23-33.
18. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002; 295:1070-1073.
19. Fu Y, Zhong H, Wang MH, et al. Intrinsically photosensitive retinal ganglion cells detect light with a vitamin A-based photopigment, melanopsin. Proc Natl Acad Sci U S A 2005; 102:10339-10344.
20. Panda S, Provencio I, Tu DC, et al. Melanopsin is required for nonimageforming photic responses in blind mice. Science 2003; 301:525-527.
21. Provencio I, Jiang G, De Grip WJ, et al. Melanopsin: An opsin in melanophores, brain, and eye. Proc Natl Acad Sci U S A 1998; 95:340-345.
22. Lin B, Koizumi A, Tanaka N, et al. Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin. Proc Natl Acad Sci U S A 2008; 105:16009-16014.
23. Watson W. An Account of Franklin's Treatise. Phil Trans Roy Soc 1751; 47:202-211; http://franklinpapers.org/franklin/framedVolumes.jsp?vol=4& page=136a.
24. Foerster O. Beitrage zur Pathophysiologie der Sehbahn und der Sehsphare. [Contributions to the pathophysiology of the optic tract and the visual sphere (cortex).] Journal fur Psychologie und Neurologie 1929; 39:463-485.
25. Brindley GS, Lewin WS. The sensations produced by electrical stimulation of the visual cortex. J Physiol 1968; 196:479-493.
26. Weiland JD, Cho AK, Humayun MS. Retinal prostheses: Current clinical results and future needs. Ophthalmology 2011; 118:2227-2237.
27. Rizzo JF 3rd, Shire DB, Kelly SK, et al. Overview of the boston retinal prosthesis: Challenges and opportunities to restore useful vision to the blind. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 2011; 2011:7492-7495.
28. Garg S. Retinal Prosthesis. Rev Ophthalmol 2012; 119:779-788.
29. Humayun MS, Dorn JD, da Cruz L, et al. Interim results from the international trial of Second Sight's visual prosthesis. Ophthalmology 2012; 119:779-788.
30. Da Cruz L, Coley BF, Dorn J, et al. The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss. Br J Ophthalmol 2013.
31. Parikh N, Itti L, Humayun M, Weiland J. Performance of visually guided tasks using simulated prosthetic vision and saliency-based cues. J Neur Eng 2013; 10:026017. [Epub ahead of print]
32. Greenberg RJ, Velte TJ, Humayun MS, et al. A computational model of electrical stimulation of the retinal ganglion cell. IEEE Trans Biomed Eng 1999; 46:505-514.
33. Lakhanpal RR, Yanai D, Weiland JD, et al. Advances in the development of visual prostheses. Curr Opin Ophthalmol 2003; 14:122-127.
34. Opie NL, Greferath U, Vessey KA, et al. Retinal prosthesis safety: Alterations in microglia morphology due to thermal damage and retinal implant contact. Invest Ophthalmol Vis Sci 2012; 53:7802-7812.
35. Sailer H, Shinoda K, Blatsios G, et al. Investigation of thermal effects of infrared lasers on the rabbit retina: A study in the course of development of an active subretinal prosthesis. Graefe's Arch Clin Exp Ophthalmol 2007; 245:1169-1178.
36. Stingl K, Bartz-Schmidt KU, Besch D, et al. Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS. Proc Biol Sci 2013; 280:20130077.
37. Wilke R, Gabel VP, Sachs H, et al. Spatial resolution and perception of patterns mediated by a subretinal 16-electrode array in patients blinded by hereditary retinal dystrophies. Invest Ophthalmol Vis Sci 2011; 52:5995-6003.
38. Zrenner E, Bartz-Schmidt KU, Benav H, et al. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci 2011; 278:1489-1497.
39. Shire DB, Ellersick W, Kelly SK, et al. ASIC design and data communications for the Boston retinal prosthesis. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Eng Med Biol Soc Confer 2012; 2012:292-295. Another overview of the Boston Subretinal Implant, including information on the new design
40. Fujikado T, Kamei M, Sakaguchi H, et al. Testing of semichronically implanted retinal prosthesis by suprachoroidal-transretinal stimulation in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci 2011; 52: 4726-4733.
41. Wong YT, Chen SC, Kerdraon YA, et al. Efficacy of supra-choroidal, bipolar, electrical stimulation in a vision prosthesis. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Eng Med Biol Soc Confer 2008; 2008:1789-1792.
42. Tsai D, Chen S, Protti DA, et al. Responses of retinal ganglion cells to extracellular electrical stimulation, from single cell to population: Model-based analysis. PloS One 2012; 7:e53357.
43. This study demonstrates that this Australian suprachoroidal implant can stimulates retinal ganglion cells
44. Zhou JA, Woo SJ, Park SI, et al. A suprachoroidal electrical retinal stimulator design for long-term animal experiments and in vivo assessment of its feasibility and biocompatibility in rabbits. J Biomed Biotechnol 2008; 2008:547428.
45. Chow AY, Chow VY, Packo KH, et al. The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa. Arch Ophthalmol 2004; 122:460-469.
46. Pardue MT, Phillips MJ, Yin H, et al. Neuroprotective effect of subretinal implants in the RCS rat. Invest Ophthalmol Vis Sci 2005; 46:674-682.
47. DeMarco PJ Jr, Yarbrough GL, Yee CW, et al. Stimulation via a subretinally placed prosthetic elicits central activity and induces a trophic effect on visual responses. Invest Ophthalmol Vis Sci 2007; 48:916-926.
48. Morimoto T, Miyoshi T, Matsuda S, et al. Transcorneal electrical stimulation rescues axotomized retinal ganglion cells by activating endogenous retinal IGF-1 system. Invest Ophthalmol Vis Sci 2005; 46:2147-2155.
49. Morimoto T, Kanda H, Kondo M, et al. Transcorneal electrical stimulation promotes survival of photoreceptors and improves retinal function in rhodopsin P347L transgenic rabbits. Invest Ophthalmol Vis Sci 2012; 53:4254-4261.
50. Henrich-Noack P, Voigt N, Prilloff S, et al. Transcorneal electrical stimulation alters morphology and survival of retinal ganglion cells after optic nerve damage. Neurosci Letters 2013; 543:1-6.
51. Inomata K, Shinoda K, Ohde H, et al. Transcorneal electrical stimulation of retina to treat longstanding retinal artery occlusion. Graefe's Arch Clin Exp Ophthalmol 2007; 245:1773-1780.
52. Schatz A, Rock T, Naycheva L, et al. Transcorneal electrical stimulation for patients with retinitis pigmentosa: A prospective, randomized, sham-controlled exploratory study. Invest Ophthalmol Vis Sci 2011; 52:4485-4496.
53. Schatz A, Arango-Gonzalez B, Fischer D, et al. Transcorneal electrical stimulation shows neuroprotective effects in retinas of light-exposed rats. Invest Ophthalmol Vis Sci 2012; 53:5552-5561.